PFE · 10-Q · 2026Q3 · Full report

Supply Chain Constraints

PFIZER INC · 2026-11-03 · Importance 7 · Surprise 6

Pfizer reported no significant supply-chain disruption during the first nine months of 2026 or through the filing date, with substantially all global manufacturing sites operating at or near normal levels. The company said it did not anticipate raw-material availability to significantly affect 2026 operations, while continuing to monitor potential disruptions associated with geopolitical and trade negotiations. Pfizer noted that such disruptions could affect costs.

Key facts

• Pfizer does not currently anticipate raw-material availability to significantly affect 2026 operations, but is monitoring potential disruptions from geopolitical and trade negotiations that could impact costs. source
• Pfizer reported no significant supply-chain disruption in the first nine months of 2026 or through the filing date, and substantially all global manufacturing sites operated at or near normal levels. source